CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Content managed by and international Editorial Board, chaired by Professor Desmond Julian
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals
Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Cardiovascular News



Page summary
Text size
News quick search
Cardiovascular news provides daily news updates to help you stay informed.
 

Erectile dysfunction common in Chinese men with Type 2 diabetes


6 September 2010

MedWire News: Erectile dysfunction (ED) affects three-quarters of Chinese men with Type 2 diabetes, say researchers who add that the majority of such men can be successfully treated with sildenafil citrate.

Significant risk factors for ED in these men included older age, longer duration of diabetes, and a glycated hemoglobin (HbA1c) level higher than 6.5%. Changyu Pan (Chinese PLA General Hospital, Beijing) and colleagues recruited 5477 men with Type 2 diabetes, aged 54.2 years on average. Of the cohort, 75.2% had ED, as defined by a score of 21 or less on the International Index of Erectile Function (IIEF)-5.

Compared with diabetic men without ED, patients with ED were significantly older, and had higher blood pressure and blood glucose. They were also more likely to have hypertension and heart disease, and they had a significantly longer duration of diabetes and lower body mass indices.

These findings are in agreement with previous studies linking ED with Type 2 diabetes and increased risk for heart disease, as reported by MedWire News.

Men who were diagnosed with ED and who consented to treatment (n=389) were given three tablets of sildenafil citrate 100 mg/day for use over 3 months. Efficacy was assessed using the IIEF-5 and the Global Efficacy Questionnaire (GEQ).

Overall, 84% of patients reported improved erectile function following treatment, with improvements maintained even after discontinuation of treatment in the majority of cases.

Adverse events were generally minor, and 37 were reported by 25 patients. These included flushing (17 events), headache (seven events), mild palpitations (two events), and dry mouth (two events).

“This report represents the largest epidemiological study to assess the prevalence of ED in Chinese men with Type 2 diabetes mellitus to date,” write the authors in the International Journal of Impotence Research.

“Because of the high prevalence of ED, clinicians should provide early screening and treatment for ED to patients with diabetes mellitus,” they add.

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010

Int J Impot Res 2010; Advance online publication



© Copyright Springer Healthcare Ltd, 2012

Related Content

Congress Reports
AHA 2011

EASD 2011

Your opinion matters – help to shape the future of InCirculation.net by completing our short survey. Click here!

To receive our weekly newsletter, register or update your profile. Click here!
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions